Telemonitoring in Patients With Heart Failure
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Heart Failure, Congestive
- Sponsor
- Maastricht University Medical Center
- Enrollment
- 382
- Locations
- 3
- Primary Endpoint
- To what extent does the use of Health Buddy result in a decrease in hospital admissions?
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
The purpose of this study is to investigate if telemonitoring results in a decrease in hospital admissions, with equal quality of care defined as mortality, quality of life and unplanned visits with caregivers. Telemonitoring is expected to be more cost-effective than usual care in patients with heart failure.
Investigators
Josiane Boyne
RN,MA
Maastricht University Medical Center
Eligibility Criteria
Inclusion Criteria
- •Patients \> 18 years
- •Patients with heart failure NYHA classification II-III-IV
- •Patient experienced a period of fluid retention
- •Patient is treated by a cardiologist
- •Patient is followed-up by a heart failure nurse
- •Adequate knowledge of the Dutch language
- •Patient has an active telephone connection, preferably analogue
- •Patient is mental competent
- •Patient has the disposal of a balance
Exclusion Criteria
- •Patients suffering from COPD, Gold classification 3 or 4
- •Patient is a dialysis patient
- •Patient has a visual restriction to read the dialogues on the Health Buddy
- •Patient is hard of hearing or deaf
- •Patient suffers from a lethal sickness with a prognosis \< 1 year
- •Patient participates in another trial
- •Patient needs a hospital admission on short time, i.e., \< 3 months
- •Patient used the Health Buddy in an earlier stage
- •Patient is an illiterate person.
Outcomes
Primary Outcomes
To what extent does the use of Health Buddy result in a decrease in hospital admissions?
Time Frame: one year
To what extent will the amount of planned contacts decrease without an increase of unplanned contacts?
Time Frame: one year
To what extent is Health Buddy® more cost-effective than usual care?
Time Frame: one year
Secondary Outcomes
- What is the effect of Health Buddy® in patients with heart failure in regard to drug consumption and therapy compliance and level of knowledge, and quality of life?(one year)
- To what extent is it - based on patients' characteristics - possible to identify patient with benefits?(one year)